NBY | NovaBay Pharmaceuticals Inc 1.16 -0.03 (-2.61%)
Category: Consumer goods
Industry: Drug Manufacturers - Other Quick infos Trade prices Volume: Market Cap: Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: April 1, 2021
Earnings History Date EPS / Forecast Revenue / Forecast May 13, 2021 April 1, 2021 November 12, 2020 -0.08 / -0.042.17M / 2.53MAugust 6, 2020 -0.15 / -0.063.98M / 3MBeat! May 7, 2020 -0.06 / -0.071.89M / 2.1Mview more
Historical Data Date Price Open High Low Vol Change ER Feb 11, 2021 1.1800 1.2100 1.2200
1.1400
3.13M -0.84% Feb 10, 2021 1.1900 1.2500 1.2600
1.0700
5.78M -0.83% Feb 9, 2021 1.2000 1.2500 1.2600
1.1300
6.15M -2.44% Feb 8, 2021 1.2300 1.0400 1.2300
1.0300
12.68M 23% Feb 5, 2021 1.0000 1.0100 1.0400
0.9308
3.43M -0.99% Feb 4, 2021 1.0100 0.9700 1.0400
0.9602
4.51M 6.45% Feb 3, 2021 0.9488 0.9100 0.9688
0.9031
2.35M 4.67% Feb 2, 2021 0.9064 0.9000 0.9614
0.9000
2.50M -0.9% Feb 1, 2021 0.9147 0.8900 0.9348
0.8715
2.15M 2.78% Jan 29, 2021 0.8900 0.9030 0.9350
0.8500
4.17M -2.51% view more
News
NovaBay Announces that Avenova is Now Available with "Subscribe & Save" finance.yahoo.com Sep 8, 2020 6:50 am
Why NovaBay's Stock Is Trading Higher Today finance.yahoo.com Aug 18, 2020 12:05 pm
NovaBay Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com Aug 7, 2020 2:30 pm
NovaBay Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com Aug 7, 2020 2:30 pm
NovaBay Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com Aug 7, 2020 12:00 pm NovaBay's stock more than triples after Avenova made available on Amazon without prescription marketwatch.com Aug 7, 2020 7:55 am NovaBay EPS misses by $0.09, beats on revenue seekingalpha.com Aug 7, 2020 4:25 am NovaBay rallies on data showing effectiveness of Avenova in killing coronavirus seekingalpha.com Jul 13, 2020 7:34 pm Protective equipment makers rise after statewide Texas mask mandate seekingalpha.com Jul 3, 2020 6:26 am
NovaBay Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com Aug 7, 2020 11:00 am
Analysts Estimate NovaBay Pharmaceuticals (NBY) to Report a Decline in Earnings: What to Look Out for finance.yahoo.com Aug 7, 2020 10:30 am
Avenova from NovaBay Pharmaceuticals Effective for Painful Eye Condition finance.yahoo.com Aug 7, 2020 10:00 am
NovaBay Pharmaceuticals Announces CFO Transition finance.yahoo.com Aug 7, 2020 6:50 am
NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE finance.yahoo.com Aug 7, 2020 6:50 am
NovaBay Pharmaceuticals Receives Approval for Distribution of Avenova in Australia finance.yahoo.com Aug 7, 2020 6:50 am
NovaBay Pharmaceuticals Reports Second Quarter 2020 Financial Results finance.yahoo.com Aug 6, 2020 4:05 pm
NovaBay Pharmaceuticals Announces Laboratory Results Confirm Avenova Kills SARS-CoV-2 (COVID-19 Virus) finance.yahoo.com Jul 13, 2020 6:50 am NovaBay EPS beats by $0.01, misses on revenue seekingalpha.com May 8, 2020 4:21 am
NovaBay Pharmaceuticals Reports First Quarter 2020 Financial Results finance.yahoo.com May 7, 2020 4:05 pm
NovaBay Pharmaceuticals to Hold First Quarter 2020 Conference Call on May 7, 2020 finance.yahoo.com Apr 27, 2020 4:15 pm Talk about NovaBay Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.